Timothy Lubenow to Treatment Outcome
This is a "connection" page, showing publications Timothy Lubenow has written about Treatment Outcome.
Connection Strength
0.058
-
Six Month Interim Outcomes from SECURE: A Single arm, Multicenter, Prospective, Clinical Study on a Novel Minimally Invasive Posterior Sacroiliac Fusion Device. Expert Rev Med Devices. 2022 May; 19(5):451-461.
Score: 0.027
-
DRG FOCUS: A Multicenter Study Evaluating Dorsal Root Ganglion Stimulation and Predictors for Trial Success. Neuromodulation. 2019 Jan; 22(1):61-79.
Score: 0.020
-
Comparison of epidural butamben to celiac plexus neurolytic block for the treatment of the pain of pancreatic cancer. Clin J Pain. 2000 Dec; 16(4):304-9.
Score: 0.006
-
Nerve blocks with 5% butamben suspension for the treatment of chronic pain syndromes. Reg Anesth Pain Med. 1998 Jul-Aug; 23(4):395-401.
Score: 0.005